🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I/II trial studies the best dose and side effects of glutaminase...
Status
Completed
Location
Vanderbilt-Ingram Cancer Center
Start Date
2017-08-23
Trial ID
NCT03263429
Tthe primary objective of this study is to compare blinded Independent Radi...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2018-04-24
Trial ID
NCT03428217
Treatments Being Tested
Many tumor cells, in contrast to normal cells, have been shown to require t...
Status
Completed
Location
UCSF Helen Diller Family Comprehensive Cancer Center
Start Date
2014-02
Trial ID
NCT02071862
The purpose of this protocol is to investigate the efficacy of the combinat...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2021-09-01
Trial ID
NCT03944902
Treatments Being Tested
This phase Ib trial studies the side effects and best dose of telaglenastat...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2020-03-16
Trial ID
NCT03831932
This study is designed to formally evaluate the impact of famotidine, an H2...
Status
Completed
Location
Nucleus Network Brisbane Clinic (formerly Q-Pharm)
Start Date
2020-09-22
Trial ID
NCT04540965
Treatments Being Tested
This study has two portions. The main goal of the Phase I portion of this r...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2016-09-12
Trial ID
NCT02861300
Treatments Being Tested
This is a Phase 2, randomized, multicenter, double-blind study of the gluta...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2020-07-24
Trial ID
NCT04265534
The research study is being conducted to evaluate the effectiveness of a dr...
Status
Not Yet Recruiting
Location
UPMC Presybeterian
Start Date
2026-08
Trial ID
NCT07223528
Treatments Being Tested
This phase I trial studies the best dose of CB-839 HCl when given together ...
Status
Active Not Recruiting
Location
Yale University
Start Date
2019-07-08
Trial ID
NCT03798678
Treatments Being Tested